Evolva Holding SA, a biosynthetic company, discovers, develops, manufactures, and commercializes ingredients for nutrition, health care, and wellness products in Switzerland and internationally. The company’s principal products include Resveratrol, a natural compound produced in grapes and other plants as a response against environmental stress factors; Vanillin, a complex blend of compounds extracted from the seed pods of the vanilla orchid; and Stevia, a natural, zero-calorie food, and beverage sweetener derived from Stevia rebaudiana, a leafy green plant for family. It also offers Nootkatone, a citrus ingredient associated with grapefruits, which is used as a flavor and fragrance ingredient; and as agent against a range of insect pests, including ticks, bed bugs, and mosquitoes. In addition, the company provides Agarwood for perfume makers and traditional medicine practitioners; Saffron, a spice made by yeast fermentation; Valencene, an orange flavor and fragrance ingredient used in food and drink, personal care, and household products, as well as an intermediate to produce nootkatone; and Sandalwood, an oil used in preparing various types of perfume compositions. Further, it offers legacy products, such as EV-077, a compound for diabetic nephropathy and other diabetic complications; EV-35, a preclinical antibiotic; and Pomecins, an antifungal ingredient that prevent mould and yeast growth. The company is based in Reinach, Switzerland.
evolva holding sa (EVE:SIX Swiss Ex)
Phone: 41 61 485 2000
|GLG Life Tech Corp||C$0.28 CAD||-0.055|
|Ingredion Inc||$80.89 USD||-0.08|
|PureCircle Ltd||406.25 GBp||-1.00|
|Stevia First Corp||$0.19 USD||-0.005|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact EVOLVA HOLDING SA, please visit www.evolva.com. Company data is provided by Capital IQ. Please use this form to report any data issues.